Header Logo

Connection

Christopher Seder to Programmed Cell Death 1 Receptor

This is a "connection" page, showing publications Christopher Seder has written about Programmed Cell Death 1 Receptor.
  1. Neoadjuvant programmed cell death 1 blockade combined with chemotherapy for resectable esophageal squamous cell carcinoma. J Immunother Cancer. 2022 01; 10(1).
    View in: PubMed
    Score: 0.201
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.